Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

Tergus Pharma announced a partnership with Great Point Partners and construction of a new commercial manufacturing facility in North Carolina. 

Tergus Pharma Plans Commercial Manufacturing Facility

CDMO iBio introduced cGMP sterile fill/finish services at its facility in Texas.

iBio Launches Sterile Fill/Finish Services

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

With an increased focus on the supply chain security of non-cGMP intermediates, companies need to re-emphasize upstream manufacturing.

Filling the Early Intermediate Security Gap

Agnes Shanley is senior editor of Pharmaceutical Technology.

Continuous manufacturing may offer huge opportunities, but it will not be right for
every facility or product.


Batch or Continuous? Ask the Right Questions During Scale Up

New offering from Catalent targets integrated development and manufacturing of biologic drugs.

Catalent Announces OneBio Suite

By connecting manufacturing processes and logistics technology, GE Healthcare and World Courier look to accelerate the development of advanced therapies.

GE Healthcare, World Courier Announce Supply Chain Collaboration

Expanded controlled substance capabilities enables Particle Sciences to develop and manufacture Schedule I–V drugs.

Particle Sciences Gains DEA Schedule I Registration

Nick Marr is the Northeast Region Sales Manager at Aggreko, nick.marr@aggreko.com

Temporary power, HVAC, and oil-free compressor systems provide flexibility and control for pharmaceutical manufacturing facilities.

Tips to Manage Temporary Power, Cooling, and Heating

Catalent expands gene therapy capabilities with $1.2-billion acquisition of Paragon Bioservices.

Catalent Closes Acquisition of Paragon Bioservices

A CPhI Middle East & Africa (MEA) expert has forecasted a boom in manufacturing in the region and has expectations that within five years some of the industry will be acting as contract manufacturers for the European market.